Related references
Note: Only part of the references are listed.Prognostic implications of EGFR and HER-2 alteration assessed by immunohistochemistry and silver in situ hybridization in gastric cancer patients following curative resection
Ho Suk Oh et al.
GASTRIC CANCER (2014)
Phase I and pharmacodynamic study of vorinostat combined with capecitabine and cisplatin as first-line chemotherapy in advanced gastric cancer
Changhoon Yoo et al.
INVESTIGATIONAL NEW DRUGS (2014)
Phase I study evaluating the combination of lapatinib (a Her2/Neu and EGFR inhibitor) and everolimus (an mTOR inhibitor) in patients with advanced cancers: South West Oncology Group (SWOG) Study S0528
Shirish M. Gadgeel et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Gene methylation in gastric cancer
Yiping Qu et al.
CLINICA CHIMICA ACTA (2013)
p21WAF1 and tumourigenesis: 20 years after
Noel A. Warfel et al.
CURRENT OPINION IN ONCOLOGY (2013)
Prognostic and Putative Predictive Biomarkers of Gastric Cancer for Personalized Medicine
Viktoria S. Warneke et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2013)
DNA Methylation of NDRG2 in Gastric Cancer and Its Clinical Significance
Xiaojing Chang et al.
DIGESTIVE DISEASES AND SCIENCES (2013)
Zinc-finger protein 545 is a novel tumour suppressor that acts by inhibiting ribosomal RNA transcription in gastric cancer
Shiyan Wang et al.
GUT (2013)
Chemotherapy for Advanced Gastric Cancer: Review and Update of Current Practices
Sung Chul Park et al.
GUT AND LIVER (2013)
Molecular Pathogenesis of Gastric Cancer
Ceu Figueiredo et al.
HELICOBACTER (2013)
Somatic Mutations and Deletions of the E-Cadherin Gene Predict Poor Survival of Patients With Gastric Cancer
Giovanni Corso et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Everolimus for Previously Treated Advanced Gastric Cancer: Results of the Randomized, Double-Blind, Phase III GRANITE-1 Study
Atsushi Ohtsu et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Apatinib for Chemotherapy-Refractory Advanced Metastatic Gastric Cancer: Results From a Randomized, Placebo-Controlled, Parallel-Arm, Phase II Trial
Jin Li et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Gastric cancer epidemiology and risk factors
Douglas E. Guggenheim et al.
JOURNAL OF SURGICAL ONCOLOGY (2013)
Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial
Florian Lordick et al.
LANCET ONCOLOGY (2013)
Prognostic significance of BRCA1 expression in gastric cancer
Wenjiao Chen et al.
MEDICAL ONCOLOGY (2013)
Epidemiology and Risk Factors for Gastroesophageal Junction Tumors: Understanding the Rising Incidence of This Disease
Matthew F. Buas et al.
SEMINARS IN RADIATION ONCOLOGY (2013)
Loss of BRCA1 expression leads to worse survival in patients with gastric carcinoma
Zi-Zhen Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
DNA and histone methylation in gastric carcinogenesis
Danielle Queiroz Calcagno et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Green tea and the risk of gastric cancer: Epidemiological evidence
I-Chun Hou et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
HER2 therapies and gastric cancer: A step forward
Ramon Andrade de Mello et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer
Jing Shi et al.
BMC CANCER (2012)
Stepwise Cumulation of RUNX3 Methylation Mediated by Helicobacter pylori Infection Contributes to Gastric Carcinoma Progression
Xiao-Xiao Lu et al.
CANCER (2012)
High CpG island methylator phenotype is associated with lymph node metastasis and prognosis in gastric cancer
Hua-Yun Chen et al.
CANCER SCIENCE (2012)
Wnt/β-Catenin Signaling and Disease
Hans Clevers et al.
CELL (2012)
Quantitative assessment of gene methylation and their impact on clinical outcome in gastric cancer
Demao Yao et al.
CLINICA CHIMICA ACTA (2012)
Epigenetic modifications in cancer
R. Kanwal et al.
CLINICAL GENETICS (2012)
Targeting the PI3K signaling pathway in cancer therapy
Chandra Bartholomeusz et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
E-cadherin dysfunction in gastric cancer - Cellular consequences, clinical applications and open questions
Patricia Carneiro et al.
FEBS LETTERS (2012)
Frequent Gene Amplification Predicts Poor Prognosis in Gastric Cancer
Jing Shi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Recent Development of Gastric Cancer Prevention
Mototsugu Kato et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2012)
Alterations of the TP53 Gene in Gastric and Esophageal Carcinogenesis
Marilanda Ferreira Bellini et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
Novel targeted agents for gastric cancer
Lian Liu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2012)
Concordant repression and aberrant methylation of transforming growth factor-beta signaling pathway genes occurs early in gastric cardia adenocarcinoma
Wei Guo et al.
MOLECULAR BIOLOGY REPORTS (2012)
Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes
Zhi Jiang Zang et al.
NATURE GENETICS (2012)
Targeted Therapy in the Management of Advanced Gastric Cancer: Are We Making Progress in the Era of Personalized Medicine?
Hilda Wong et al.
ONCOLOGIST (2012)
High-Throughput Mutation Profiling Identifies Frequent Somatic Mutations in Advanced Gastric Adenocarcinoma
Jeeyun Lee et al.
PLOS ONE (2012)
Genetic Aspects of Gastric Cancer Instability
Petra Hudler
SCIENTIFIC WORLD JOURNAL (2012)
Gastric intestinal metaplasia revisited: function and regulation of CDX2
Rita Barros et al.
TRENDS IN MOLECULAR MEDICINE (2012)
Alterations in the human epidermal growth factor receptor 2-phosphatidylinositol 3-kinase-v-Akt pathway in gastric cancer
Yasutaka Sukawa et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Wnt Signaling in Cancer
Paul Polakis
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer
S. Iqbal et al.
ANNALS OF ONCOLOGY (2011)
Cigarette smoking, cyclooxygenase-2 pathway and cancer
Run-Yue Huang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2011)
Gastric cancers of Western European and African patients show different patterns of genomic instability
Tineke E. Buffart et al.
BMC MEDICAL GENOMICS (2011)
Phase I trial of capecitabine plus everolimus (RAD001) in patients with previously treated metastatic gastric cancer
Taekyu Lim et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Insufficient role of cell proliferation in aberrant DNA methylation induction and involvement of specific types of inflammation
Keun Hur et al.
CARCINOGENESIS (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Clinical Significance of miR-146a in Gastric Cancer Cases
Ryunosuke Kogo et al.
CLINICAL CANCER RESEARCH (2011)
MicroRNA-125a-5p Is an Independent Prognostic Factor in Gastric Cancer and Inhibits the Proliferation of Human Gastric Cancer Cells in Combination with Trastuzumab
Naohiro Nishida et al.
CLINICAL CANCER RESEARCH (2011)
A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis
Rui Liu et al.
EUROPEAN JOURNAL OF CANCER (2011)
Oncogenic mutations in gastric cancer with microsatellite instability
Giovanni Corso et al.
EUROPEAN JOURNAL OF CANCER (2011)
Prognostic Implications of Altered Human Epidermal Growth Factor Receptors (HERs) in Gastric Carcinomas: HER2 and HER3 Are Predictors of Poor Outcome
Maria D. Begnami et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study
Atsushi Ohtsu et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Analysis of DNA copy Number Aberrations by Multiple Ligation-Dependent Probe Amplification on 50 Intestinal Type Gastric Cancers
Dai Zhang et al.
JOURNAL OF SURGICAL ONCOLOGY (2011)
Pathobiologic implications of methylation and expression status of Runx3 and CHFR genes in gastric cancer
Shi-Lian Hu et al.
MEDICAL ONCOLOGY (2011)
Methylation of BNIP3 and DAPK indicates lower response to chemotherapy and poor prognosis in gastric cancer
Hirofumi Sugita et al.
ONCOLOGY REPORTS (2011)
Gene Expression Signature Analysis Identifies Vorinostat as a Candidate Therapy for Gastric Cancer
Sofie Claerhout et al.
PLOS ONE (2011)
The Epigenetic Modifier PRDM5 Functions as a Tumor Suppressor through Modulating WNT/β-Catenin Signaling and Is Frequently Silenced in Multiple Tumors
Xing-sheng Shu et al.
PLOS ONE (2011)
CD44-SLC1A2 Gene Fusions in Gastric Cancer
Jiong Tao et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Deep Sequencing of Patient Genomes for Disease Diagnosis: When Will It Become Routine?
Stephen F. Kingsmore et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Genetic mutations of p53 and k-ras in gastric carcinoma patients from Hunan, China
Han-chun Chen et al.
TUMOR BIOLOGY (2011)
Mechanisms Regulating Microtubule Binding, DNA Replication, and Apoptosis are Controlled by the Intestinal Tumor Suppressor APC
Erin M. Perchiniak et al.
CURRENT COLORECTAL CANCER REPORTS (2011)
Pathological roles of MAPK signaling pathways in human diseases
Eun Kyung Kim et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
Dysregulation of cellular signaling in gastric cancer
William K. K. Wu et al.
CANCER LETTERS (2010)
Inflammatory Processes Triggered by Helicobacter pylori Infection Cause Aberrant DNA Methylation in Gastric Epithelial Cells
Tohru Niwa et al.
CANCER RESEARCH (2010)
MicroRNA-375 Is Downregulated in Gastric Carcinomas and Regulates Cell Survival by Targeting PDK1 and 14-3-3ζ
Yoshiyuki Tsukamoto et al.
CANCER RESEARCH (2010)
Role of Helicobacter pylori infection in aberrant DNA methylation along multistep gastric carcinogenesis
Cheol Min Shin et al.
CANCER SCIENCE (2010)
Gastric Cancer: Epidemiology and Risk Factors
Guenter J. Krejs
DIGESTIVE DISEASES (2010)
MicroRNA-130b regulates the tumour suppressor RUNX3 in gastric cancer
Kin Wai Lai et al.
EUROPEAN JOURNAL OF CANCER (2010)
Genetic and Epigenetic Alteration in Gastric Carcinogenesis
Carlos Resende et al.
HELICOBACTER (2010)
Epidemiology of Helicobacter pylori infection and gastric cancer in Asia
Kwong Ming Fock et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
The Role of Surgery in the Treatment of Gastric Cancer
Yingqiang Shi et al.
JOURNAL OF SURGICAL ONCOLOGY (2010)
Regulation of the transcription factor NF-κB1 by microRNA-9 in human gastric adenocarcinoma
Hai-Ying Wan et al.
MOLECULAR CANCER (2010)
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2010)
S110, a 5-Aza-2′-Deoxycytidine-Containing Dinucleotide, Is an Effective DNA Methylation Inhibitor In vivo and Can Reduce Tumor Growth
Jody C. Chuang et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis
Tetsuya Ueda et al.
LANCET ONCOLOGY (2010)
EPIGENETICS AND GENETICS A census of amplified and overexpressed human cancer genes
Thomas Santarius et al.
NATURE REVIEWS CANCER (2010)
Allelic loss of the PTEN gene and mutation of the TP53 gene in choriocarcinoma arising from gastric adenocarcinoma: analysis of loss of heterozygosity in two male patients with extragonadal choriocarcinoma
Genshu Tate et al.
CANCER GENETICS AND CYTOGENETICS (2009)
Prostaglandin E-2, Wnt, and BMP in gastric tumor mouse models
Hiroko Oshima et al.
CANCER SCIENCE (2009)
Epigenetic Modifiers: Basic Understanding and Clinical Development
Richard L. Piekarz et al.
CLINICAL CANCER RESEARCH (2009)
Gastric cancer
Vincenzo Catalano et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2009)
Does the Expression of Cyclin E, pRb, and p21 Correlate with Prognosis in Gastric Adenocarcinoma?
Gregory Kouraklis et al.
DIGESTIVE DISEASES AND SCIENCES (2009)
Sensitive and Specific Detection of Early Gastric Cancer with DNA Methylation Analysis of Gastric Washes
Yoshiyuki Watanabe et al.
GASTROENTEROLOGY (2009)
The presence of a methylation fingerprint of Helicobacter pylori infection in human gastric mucosae
Takeshi Nakajima et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Down-regulated miR-9 and miR-433 in human gastric carcinoma
Hongchun Luo et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2009)
Epigenetics in cancer: Targeting chromatin modifications
Leigh Ellis et al.
MOLECULAR CANCER THERAPEUTICS (2009)
ErbB2 resembles an autoinhibited invertebrate epidermal growth factor receptor
Diego Alvarado et al.
NATURE (2009)
OPINION Is NF-κB a good target for cancer therapy? Hopes and pitfalls
Veronique Baud et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells
S. H. Lee et al.
ONCOGENE (2009)
High resolution analysis of DNA copy-number aberrations of chromosomes 8, 13, and 20 in gastric cancers
Tineke E. Buffart et al.
VIRCHOWS ARCHIV (2009)
Comparative Study on Overexpression of HER2/neu and HER3 in Gastric Cancer
Xiu Li Zhang et al.
WORLD JOURNAL OF SURGERY (2009)
Cancer prevention by tea: animal studies, molecular mechanisms and human relevance
Chung S. Yang et al.
NATURE REVIEWS CANCER (2009)
Current status of epigenetic treatment in myelodysplastic syndromes
Andrea Kuendgen et al.
ANNALS OF HEMATOLOGY (2008)
The global histone modification pattern correlates with cancer recurrence and overall survival in gastric adenocarcinoma
Young Soo Park et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres
Qing Ji et al.
BMC CANCER (2008)
PRL PTPs: mediators and markers of cancer progression
Darrell C. Bessette et al.
CANCER AND METASTASIS REVIEWS (2008)
Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer
Geoffrey Y. Ku et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
The cell-cell adhesion molecule E-cadherin
F. van Roy et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Geographic distribution of liver and stomach cancers in Thailand in relation to estimated dietary intake of nitrate, nitrite, and nitrosodimethylamine
Eugene J. Mitacek et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2008)
Nutrition and gastric cancer risk: an update
Chun Liu et al.
NUTRITION REVIEWS (2008)
Methylated TMS1 and DAPK genes predict prognosis and response to chemotherapy in gastric cancer
Keiji Kato et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
DNA methylation profiles of gastric carcinoma characterized by quantitative DNA methylation analysis
Gyeong Hoon Kang et al.
LABORATORY INVESTIGATION (2008)
Phosphoinositide 3-kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death
Hong-Gang Yu et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Aberrant methylation of p16 predicts candidates for 5-fluorouracil-based adjuvant therapy in gastric cancer patients
Mayumi Mitsuno et al.
JOURNAL OF GASTROENTEROLOGY (2007)
Vorinostat in cutaneous T-CELL lymphoma
Madeleine Duvic et al.
DRUGS OF TODAY (2007)
Subsite-specific risk factors for esophageal and gastric adenocarcinoma
Sarah J. Crane et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer
M. Nojima et al.
ONCOGENE (2007)
Delivery of 5-aza-2′-deoxycytidine to cells using oligodeoxynucleotides
Christine B. Yoo et al.
CANCER RESEARCH (2007)
Oxidative stress expression status associated to Helicobacter pylori virulence in gastric diseases
Amanda C. Augusto et al.
CLINICAL BIOCHEMISTRY (2007)
Diet and the risk of gastric cancer: review of epidemiological evidence
Shoichiro Tsugane et al.
GASTRIC CANCER (2007)
Wnt signaling and gastrointestinal tumorigenesis in mouse models
M. M. Taketo
ONCOGENE (2006)
Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion
Manabu Kurayoshi et al.
CANCER RESEARCH (2006)
Alternative pathways of NF-κB activation:: A double-edged sword in health and disease
Gutian Xiao et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2006)
Gene amplification in cancer
Donna G. Albertson
TRENDS IN GENETICS (2006)
Impact of loss of heterozygosity of encoding phosphate and tensin homolog on the prognosis of gastric cancer
E Oki et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)
RASSF2, a potential tumour suppressor, is silenced by CpG island hypermethylation in gastric cancer
M Endoh et al.
BRITISH JOURNAL OF CANCER (2005)
ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation
H Takada et al.
ONCOGENE (2005)
Nitrate and nitrosative chemistry within Barrett's oesophagus during acid reflux
H Suzuki et al.
GUT (2005)
Mechanisms of disease: PI3K/AKT signaling in gastrointestinal cancers
P Michl et al.
ZEITSCHRIFT FUR GASTROENTEROLOGIE (2005)
ERBB2 kinase domain mutation in a gastric cancer metastasis
JW Lee et al.
APMIS (2005)
Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids
WJ Lee et al.
MOLECULAR PHARMACOLOGY (2005)
Levels of prostaglandin E metabolite, the major urinary metabolite of prostaglandin E2, are increased in smokers
ND Gross et al.
CLINICAL CANCER RESEARCH (2005)
Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer
WK Leung et al.
BRITISH JOURNAL OF CANCER (2005)
MicroRNA expression profiles classify human cancers
J Lu et al.
NATURE (2005)
Correlation of Wnt-2 expression and β-catenin intracellular accumulation in Chinese gastric cancers:: relevance with tumour dissemination
XX Cheng et al.
CANCER LETTERS (2005)
Amplification of HER-2 in gastric carcinoma:: association with Topoisomerase IIα gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab
M Tanner et al.
ANNALS OF ONCOLOGY (2005)
Salt, salted food intake, and risk of gastric cancer: Epidemiologic evidence
S Tsugane
CANCER SCIENCE (2005)
NF-κB functions as a tumour promoter in inflammation-associated cancer
E Pikarsky et al.
NATURE (2004)
Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation
JH Park et al.
CLINICAL CANCER RESEARCH (2004)
Salt and salted food intake and subsequent risk of gastric cancer among middle-aged Japanese men and women
S Tsugane et al.
BRITISH JOURNAL OF CANCER (2004)
Oscillations in NF-κB signaling control the dynamics of gene expression
DE Nelson et al.
SCIENCE (2004)
BRAF and KRAS mutations in stomach cancer
SH Lee et al.
ONCOGENE (2003)
Biallelic inactivation of the RIZ1 gene in human gastric cancer
Y Tokumaru et al.
ONCOGENE (2003)
TP53 and gastric carcinoma: A review
CM Fenoglio-Preiser et al.
HUMAN MUTATION (2003)
Alterations of chromosomal copy number during progression of diffuse-type gastric carcinomas: metaphase- and array-based comparative genomic hybridization analyses of multiple samples from individual tumours
DF Peng et al.
JOURNAL OF PATHOLOGY (2003)
Prognostic significance of Bcl-2 and p53 expression in gastric cancer
HK Lee et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2003)
Mutational analysis of BRAF and K-ras in gastric cancers: absence of BRAF mutations in gastric cancers
IJ Kim et al.
HUMAN GENETICS (2003)
Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma
JH Lee et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Marimastat as maintenance therapy for patients with advanced gastric cancer: a randomised trial
SR Bramhall et al.
BRITISH JOURNAL OF CANCER (2002)
Loss of heterozygosity at 18q21 region in gastric cancer involves a number of cancer-related genes and correlates with stage and histology, but lacks independent prognostic value
ME Candusso et al.
JOURNAL OF PATHOLOGY (2002)
Expression of CD44v6 in advanced gastric cancer and its relationship to hematogenous metastasis and long-term prognosis
A Yamaguchi et al.
JOURNAL OF SURGICAL ONCOLOGY (2002)
Epstein-Barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma
GH Kang et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Helicobacter pylori infection and the development of gastric cancer.
N Uemura et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Mutations in the APC tumour suppressor gene cause chromosomal instability
R Fodde et al.
NATURE CELL BIOLOGY (2001)
Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2
M Murakami et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Vascular invasion and potential for tumor angiogenesis and metastasis in gastric carcinoma
Y Maehara et al.
SURGERY (2000)
Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer
WM Grady et al.
NATURE GENETICS (2000)
Share Paper
